Sponsor or institution
Clinical trials and research at Sonoma Biotherapeutics, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Sonoma Biotherapeutics, Inc. that are recruiting, in United States. By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Long-term safety follow-up after gene-modified regulatory T cell (Treg) therapy
This study will see if any delayed side effects occur over 15 years in people who previously got a Sonoma Biotherapeutics gene-modified Treg treatment for conditions like rheumatoid arthritis or hidradenitis suppurativa.
-
Testing a new treatment for rheumatoid arthritis
This study is testing a new treatment using patients' own immune cells to see if it can help reduce inflammation and improve symptoms in people with moderate-to-severe rheumatoid arthritis.
Quick answers
How many clinical trials run by Sonoma Biotherapeutics, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.